Filing Details
- Accession Number:
- 0000932440-16-000495
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-04 16:20:51
- Reporting Period:
- 2016-09-30
- Filing Date:
- 2016-10-04
- Accepted Time:
- 2016-10-04 16:20:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 827871 | Eagle Pharmaceuticals Inc. | EGRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033508 | Jay Moorin | C/O Proquest Investments 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No | |
| 1225149 | Alain Schreiber | C/O Proquest Investments 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No | |
| 1431818 | Proquest Investments Iv, L.p. | 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No | |
| 1431819 | Proquest Associates Iv Llc | 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No | |
| 1674772 | Proquest Financial Llc | 2430 Vanderbilt Beach Road, #108-190 Naples FL 34109 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $0.001 Par Value | Disposition | 2016-09-30 | 22,100 | $70.06 | 4,373,987 | No | 4 | S | Indirect | By ProQuest Investments IV, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By ProQuest Investments IV, L.P. |
Footnotes
- The shares are held by ProQuest Investments IV, L.P. ("Investments IV"), which ProQuest Financial LLC ("ProQuest Financial") manages. Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
- Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $70.00 to $70.38. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
Billionaire Hedge Funds
